Aandelen in “Gezondheidstechnologie”
| Aandeel | Datum | Koers | Evolutie |
|---|---|---|---|
C4 Therapeutics Inc |
4/02 | 3,400 USD
+1,19% |
+1,19% |
|
Cabaletta Bio Inc |
4/02 | 2,320 USD
-1,69% |
-1,69% |
|
Calithera Biosciences Inc |
29/01 | 0,001 USD
-88,00% |
-88,00% |
Cambridge Cognition Holdings plc |
29/01 | 45,500 GBX
0,00% |
0,00% |
|
Can B Corp |
4/02 | 0,033 USD
-5,71% |
-5,71% |
|
Can-Fite Biopharma Ltd |
4/02 | 1,390 USD
-4,79% |
-4,79% |
|
Capricor Therapeutics Inc |
4/02 | 15,070 USD
-0,72% |
-0,72% |
|
Cara Therapeutics Inc |
4/02 | 4,910 USD
+2,72% |
+2,72% |
Carbios |
4/02 | 6,250 EUR
-1,57% |
-1,57% |
Cardiol Therapeutics Inc - Class A |
4/02 | 2,000 CAD
+3,09% |
+3,09% |
|
Caredx Inc |
4/02 | 23,100 USD
-0,94% |
-0,94% |
|
Carisma Therapeutics, Inc. |
4/02 | 0,464 USD
+1,53% |
+1,53% |
|
Carmat |
4/02 | 0,777 EUR
-3,24% |
-3,24% |
|
CASI Pharmaceuticals Inc |
4/02 | 2,550 USD
+8,05% |
+8,05% |
|
Cassava Sciences Inc |
4/02 | 2,390 USD
+1,27% |
+1,27% |
|
Castle Biosciences Inc |
4/02 | 28,150 USD
-2,09% |
-2,09% |
|
Catalent Inc. |
17/12 | 63,480 USD
0,00% |
0,00% |
|
Catalyst Pharmaceuticals Inc |
4/02 | 23,090 USD
+2,08% |
+2,08% |
|
Cel-Sci Corp. |
4/02 | 0,384 USD
+0,92% |
+0,92% |
|
Celldex Therapeutics Inc. |
4/02 | 23,150 USD
-2,11% |
-2,11% |
|
Cellectar Biosciences Inc |
4/02 | 0,260 USD
-0,76% |
-0,76% |
|
Cellectis |
4/02 | 1,508 EUR
+0,53% |
+0,53% |
|
Cellectis |
4/02 | 1,630 USD
+4,49% |
+4,49% |
Celyad Oncology |
4/02 | 0,430 EUR
0,00% |
0,00% |
|
Cerus Corp. |
4/02 | 1,860 USD
+3,33% |
+3,33% |
|
Champions Oncology Inc |
4/02 | 10,740 USD
+7,29% |
+7,29% |
|
Charlottes Web Holdings Inc |
4/02 | 0,145 CAD
0,00% |
0,00% |
|
Check-Cap Ltd |
4/02 | 0,899 USD
+6,44% |
+6,44% |
|
Checkpoint Therapeutics Inc |
4/02 | 3,390 USD
+6,94% |
+6,94% |
|
Chimerix Inc |
4/02 | 3,930 USD
+3,42% |
+3,42% |
|
China Pharma Holdings Inc. |
4/02 | 0,206 USD
-7,63% |
-7,63% |
|
China SXT Pharmaceuticals Inc |
4/02 | 0,399 USD
+0,88% |
+0,88% |
|
Cidara Therapeutics Inc |
4/02 | 20,040 USD
+5,75% |
+5,75% |
|
Cipher Pharmaceuticals Inc |
4/02 | 13,740 CAD
+2,77% |
+2,77% |
|
Citius Pharmaceuticals Inc |
4/02 | 2,590 USD
-3,72% |
-3,72% |
|
Clean Air Metals Inc |
4/02 | 0,045 CAD
-10,00% |
-10,00% |
|
ClearPoint Neuro Inc |
4/02 | 18,370 USD
+8,38% |
+8,38% |
|
Clearside Biomedical Inc |
4/02 | 0,978 USD
+4,09% |
+4,09% |
|
Cns Pharmaceuticals Inc |
4/02 | 0,097 USD
+0,83% |
+0,83% |
|
Co-Diagnostics Inc |
4/02 | 0,722 USD
-1,77% |
-1,77% |
|
Cocrystal Pharma Inc |
4/02 | 1,970 USD
+5,35% |
+5,35% |
|
Cogent Biosciences Inc |
4/02 | 9,250 USD
+2,89% |
+2,89% |
|
CohBar Inc |
6/01 | 0,410 USD
0,00% |
0,00% |
|
Coherus Biosciences Inc |
4/02 | 1,160 USD
+4,50% |
+4,50% |
|
Collegium Pharmaceutical Inc |
4/02 | 30,930 USD
-0,87% |
-0,87% |
|
CollPlant Biotechnologies Ltd |
4/02 | 3,780 USD
+1,34% |
+1,34% |
Coloplast |
4/02 | 798,800 DKK
-2,35% |
-2,35% |
|
Compass Pathways Plc |
4/02 | 4,730 USD
+9,74% |
+9,74% |
|
Compass Therapeutics Inc |
4/02 | 3,120 USD
+1,30% |
+1,30% |
|
Compugen Ltd. |
4/02 | 2,370 USD
+3,04% |
+3,04% |
|
Conmed Corp. |
4/02 | 72,880 USD
+2,35% |
+2,35% |
|
Convatec Group |
4/02 | 238,800 GBX
-1,65% |
-1,65% |
|
Cooper Companies, Inc. |
4/02 | 95,300 USD
-0,04% |
-0,04% |
|
Corbus Pharmaceuticals Holdings Inc |
4/02 | 9,650 USD
+1,47% |
+1,47% |
|
Corcept Therapeutics Inc |
4/02 | 66,910 USD
+0,54% |
+0,54% |
|
CorMedix Inc |
4/02 | 10,480 USD
+6,29% |
+6,29% |
|
Corvus Pharmaceuticals Inc |
4/02 | 5,340 USD
+5,33% |
+5,33% |
|
Covalon Technologies Ltd. |
4/02 | 3,070 CAD
-0,65% |
-0,65% |
|
Creo Medical Group Plc |
4/02 | 18,000 GBX
-1,37% |
-1,37% |
|
Crescita Therapeutics Inc |
4/02 | 0,600 CAD
+7,14% |
+7,14% |
|
Crinetics Pharmaceuticals Inc |
4/02 | 40,400 USD
+4,15% |
+4,15% |
|
CRISPR Therapeutics AG |
4/02 | 40,490 USD
+1,23% |
+1,23% |
|
Cronos Group Inc |
4/02 | 1,880 USD
+1,62% |
+1,62% |
|
Crossject |
4/02 | 1,882 EUR
-2,08% |
-2,08% |
|
Cryo-Cell International, Inc. |
4/02 | 7,840 USD
+3,57% |
+3,57% |
|
Cue Biopharma Inc |
4/02 | 1,410 USD
0,00% |
0,00% |
|
Cumberland Pharmaceuticals Inc. |
4/02 | 3,760 USD
+76,53% |
+76,53% |
|
CureVac N.V. |
4/02 | 3,590 USD
+1,13% |
+1,13% |
|
Curis Inc |
4/02 | 3,470 USD
-0,57% |
-0,57% |
|
Currenc Group Inc. |
4/02 | 1,530 USD
-4,38% |
-4,38% |
|
Cutera Inc |
4/02 | 0,438 USD
+2,58% |
+2,58% |
|
Cyanotech Corp. |
4/02 | 0,360 USD
-0,03% |
-0,03% |
|
Cyclacel Pharmaceuticals Inc |
4/02 | 6,750 USD
-2,17% |
-2,17% |
|
Cyclacel Pharmaceuticals Inc |
4/02 | 0,350 USD
+0,69% |
+0,69% |
|
Cyclerion Therapeutics Inc |
4/02 | 4,190 USD
-21,24% |
-21,24% |
|
Cytokinetics Inc |
4/02 | 49,200 USD
+1,52% |
+1,52% |
|
CytomX Therapeutics Inc |
4/02 | 0,864 USD
+2,83% |
+2,83% |
|
Cytosorbents Corp |
4/02 | 0,988 USD
-1,17% |
-1,17% |
Cytotools AG |
3/02 | 1,080 EUR
+12,50% |
+12,50% |